Loyal Announces $45 Million Series B Financing to Continue Development of First FDA-Approved Dog Lifespan Extension Drug for Veterinary Use [Yahoo! Finance]
Western Alliance Bancorporation (DE) (WAL)
Last western alliance bancorporation (de) earnings: 4/16 04:26 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.westernalliancebancorporation.com
Company Research
Source: Yahoo! Finance
SAN FRANCISCO, March 21, 2024 BUSINESS WIRE Loyal , a biotech company pioneering longevity drugs for dogs, today announced that it has successfully completed its Series B funding round, securing $45 million in investment. The round was led by Bain Capital Ventures. This brings total funding raised by Loyal to more than $125 million since its founding in 2019 and includes a $12 million credit facility from Bridge Bank, part of Western Alliance Bank. Most major existing investors from Loyal's previous financings – including Khosla Ventures, First Round Capital, Box Group, Collaborative Fund, Quiet Capital, and Todd & Rahul's Angel Fund – participated in this round. Bain Capital Ventures and Valor Equity Partners are new investors. "This fundraise fuels our efforts to bring to market what we hope will be the first FDA-approved drug to extend healthy lifespan," said Celine Halioua, Founder and CEO of Loyal. "All of our work is centered on giving dogs longer, healthier lives. I'm prou
Show less
Read more
Impact Snapshot
Event Time:
WAL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WAL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WAL alerts
High impacting Western Alliance Bancorporation (DE) news events
Weekly update
A roundup of the hottest topics
WAL
News
- Western Alliance: Solid Growth And Cheap Valuation (Rating Upgrade) [Seeking Alpha]Seeking Alpha
- 18 savings accounts to open for May (up to 5.55% APY) [CBS News]CBS News
- Heather Kelly Appointed as Head of Western Alliance Bank's Business Escrow Services Group [Yahoo! Finance]Yahoo! Finance
- Heather Kelly Appointed as Head of Western Alliance Bank’s Business Escrow Services GroupBusiness Wire
- Western Alliance Bancorporation (NYSE: WAL) had its price target lowered by analysts at Barclays PLC from $91.00 to $86.00. They now have an "overweight" rating on the stock.MarketBeat
WAL
Earnings
- 4/18/24 - Beat
WAL
Sec Filings
- 4/26/24 - Form 3
- 4/26/24 - Form 3
- 4/26/24 - Form 3
- WAL's page on the SEC website